CC
LLY icon

Claybrook Capital’s Eli Lilly LLY Stock Holding History

Claybrook Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,940
Closed -$445K – 188
2021
Q2 		$445K Buy
+1,940
New +$390K 0.15% 114
2019
Q1 		– Sell
-19
Closed -$2K – 421
2018
Q4 		$2K Buy
+19
New +$2.12K ﹤0.01% 639

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Claybrook Capital's LLY Position: Q3 2021 in Review

Claybrook Capital sold out of Eli Lilly (LLY) in Q3 2021, closing a stake of 1,940 shares — an estimated $445K sold.

Claybrook Capital first reported a position in LLY in Q4 2018 and held it in 2 quarters. The position peaked at $445K in Q2 2021. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Claybrook Capital reported no remaining Eli Lilly position as of Q3 2021 after selling out during the quarter.
  • Claybrook Capital sold 1,940 Eli Lilly shares in Q3 2021, an estimated $445K.
  • Claybrook Capital first reported a position in Eli Lilly in Q4 2018 and held it in 2 quarters.
  • Claybrook Capital's Eli Lilly position peaked at $445K in Q2 2021.
  • 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Claybrook Capital's 13F filing for Q3 2021, filed 15 Nov 2021.